Skip to main content
Fig. 1 | Lipids in Health and Disease

Fig. 1

From: Ergothioneine ameliorates metabolic dysfunction-Associated Steatotic Liver Disease (MASLD) by enhancing autophagy, inhibiting oxidative damage and inflammation

Fig. 1

Ergothioneine ameliorated lipid metabolism and liver impairment in HFD mice. (A) Graph of the experimental design for mice. (B) Body weight change curve of mice. The plot of the statistical analysis results and the (AUC) of IPGTT (C) and IPITT (D). Serum levels of ALT (E) and AST (F) in mice. (G) Graph of statistical analysis of mouse body fat and percentage by dual-energy X-ray absorption photometry. n = 5. ** P < 0.01, **** P < 0.0001 HFD vs. NCD; #P < 0.05, ##P < 0.01, ###P < 0.001, ####P < 0.0001 HFD + EGT vs. HFD

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X